<code id='9981C55D8B'></code><style id='9981C55D8B'></style>
    • <acronym id='9981C55D8B'></acronym>
      <center id='9981C55D8B'><center id='9981C55D8B'><tfoot id='9981C55D8B'></tfoot></center><abbr id='9981C55D8B'><dir id='9981C55D8B'><tfoot id='9981C55D8B'></tfoot><noframes id='9981C55D8B'>

    • <optgroup id='9981C55D8B'><strike id='9981C55D8B'><sup id='9981C55D8B'></sup></strike><code id='9981C55D8B'></code></optgroup>
        1. <b id='9981C55D8B'><label id='9981C55D8B'><select id='9981C55D8B'><dt id='9981C55D8B'><span id='9981C55D8B'></span></dt></select></label></b><u id='9981C55D8B'></u>
          <i id='9981C55D8B'><strike id='9981C55D8B'><tt id='9981C55D8B'><pre id='9981C55D8B'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:35678
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          What STAT readers think about the FDA and patient advocacy
          What STAT readers think about the FDA and patient advocacy

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Violet CEO on training clinicians to promote more inclusive care

          GaurangChoksiisthefounderandCEOofViolet,ahealthequityplatform.CourtesyGaurangChoksiPHOENIX,Ariz.—Gau